Startup profile · funding coverage
Mirendil funding, valuation and investors
AI-for-science platform training models expert at AI R&D for autonomous experiments.
Keep track of Mirendil
Save this profile to your VCT watchlist for a quick return.
Funding, valuation & investors
Answer-first snapshotLatest funding
Seed
Amount not disclosed · June 2026
Latest known valuation
Not publicly disclosed
Total disclosed equity funding
Not publicly disclosed
Excludes debt, grants, acquisitions, secondaries, and IPO proceeds.
Current status
private
seed
Investors in latest funding
Lead: Andreessen Horowitz
Overview
Mirendil builds AI systems specialized in AI research and development — enabling scientists to run autonomous experiments and compress discovery cycles. Andreessen Horowitz led the seed round. Team includes alumni from Anthropic, Google, and xAI.
Why Mirendil is interesting
a16z led seed for 'AI that does AI research' — team from Anthropic, Google, and xAI signals VCs treating autonomous science as infrastructure, not novelty.
Product & use cases
Mirendil trains models that are expert at AI R&D workflows — experiment design, hypothesis testing, and iterative research — so domain scientists can delegate technical AI research loops to autonomous systems.
- Autonomous AI research experiment loops
- Accelerating scientific discovery with AI agents
- AI R&D automation for biotech and deep-tech labs
Key facts
- Seed (Jun 2026): a16z led — a16z announcement
- Team from Anthropic, Google, xAI
Funding history (newest first)
Seed
2026-06Source: https://a16z.com/announcement/investing-in-mirendil/
Investors in our directory
Funds linked from Mirendil's profile — open a fund page for stage focus and related deal articles.
Competitive landscape
Edge: Team DNA from frontier AI labs (Anthropic, xAI) applied to science automation — not generic LLM wrappers.
AI-for-science is crowded with hype but few deployed systems. Mirendil's wedge is meta — AI that improves AI research itself. Different from drug-discovery plays (Isomorphic) or coding agents (Devin). Execution risk is high; a16z seed validates thesis interest.
-
FutureHouse direct
AI agents for scientific discovery.
-
Cognition (Devin) adjacent
AI software engineering agents.
-
Google DeepMind incumbent
Research lab with science AI programs.
-
Isomorphic Labs adjacent
AI drug discovery from DeepMind spin-out.
Notable stories
- a16z led Mirendil's seed arguing autonomous AI research systems could compress scientific discovery cycles — per a16z announcement June 2026.
Industries
Related funding articles
Venture Capital Tracker pieces that cover Mirendil's financing or category context.
FAQs about Mirendil
Practical answers founders, operators, and investors typically search for.
Last updated:
Editorial note: AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.